Clinical value of molecular markers as diagnostic and prognostic tools to guide treatment of thyroid cancer.

Molecular testing needs to be implemented into the local evidence-based clinical management thyroid nodule/cancer pathways to improve its diagnostic and prognostic value and to optimize cost-effectiveness.